Issues in the incorporation of economic perspectives and evidence into Cochrane reviews

BackgroundMethods for systematic reviews of the effects of health interventions have focused mainly on addressing the question of 'What works?’ or 'Is this intervention effective in achieving one or more specific outcomes?’ Addressing the question 'Is it worth it given the resources available?’ has received less attention. This latter question can be addressed by applying an economic lens to the systematic review process.This paper reflects on the value and desire for the consideration by end users for coverage of an economic perspective in a Cochrane review and outlines two potential approaches and future directions.MethodsTwo frameworks to guide review authors who are seeking to include an economic perspective are outlined. The first involves conducting a full systematic review of economic evaluations that is integrated into a review of intervention effects. The second involves developing a brief economic commentary. The two approaches share a set of common stages but allow the tailoring of the economic component of the Cochrane review to the skills and resources available to the review team.ResultsThe number of studies using the methods outlined in the paper is limited, and further examples are needed both to explore the value of these approaches and to further develop them. The rate of progress will hinge on the organisational leadership, capacity and resources available to the CCEMG, author teams and other Cochrane entities. Particular methodological challenges to overcome relate to understanding the key economic trade-offs and casual relationships for a given decision problem and informing the development of evaluations designed to support local decision-makers.ConclusionsMethods for incorporating economic perspectives and evidence into Cochrane intervention reviews are established. Their role is not to provide a precise estimate of 'cost-effectiveness’ but rather to help end-users of Cochrane reviews to determine the implications of the economic components of reviews for their own specific decisions.

[1]  G. Mowatt,et al.  Systematic review of the clinical effectiveness and cost-effectiveness of oesophageal Doppler monitoring in critically ill and high-risk surgical patients. , 2009, Health technology assessment.

[2]  S. Wilson Methods for the economic evaluation of health care programmes , 1987 .

[3]  J. Chilcott,et al.  Docetaxel for the adjuvant treatment of early node-positive breast cancer: a single technology appraisal. , 2009, Health technology assessment.

[4]  Rob W Anderson,et al.  The Role of Economic Perspectives and Evidence in Systematic Review , 2010 .

[5]  P. Neumann What next for QALYs? , 2011, JAMA.

[6]  John K. Roman,et al.  What does cost-benefit analysis add to decision making? Evidence from the criminal justice literature , 2008 .

[7]  C. Boehler Mind the Gap! - Geographic transferability of economic evaluation in health , 2012 .

[8]  Ian Shemilt,et al.  Evidence- Based decisions and economics , 2013 .

[9]  M. Mugford,et al.  From effectiveness to efficiency: an introduction to evidence-based health economics in systematic review , 2002 .

[10]  Grazyna Adamiak,et al.  Methods for the economic evaluation of health care programmes, 3rd ed , 2006 .

[11]  H. D. de Vet,et al.  Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria , 2005, International Journal of Technology Assessment in Health Care.

[12]  Michele Tarsilla Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.

[13]  F. Sassi,et al.  Equity, Efficiency and Research Synthesis , 2010 .

[14]  Renee F Wilson,et al.  Assessing the Impact of Economic Evidence on Policymakers in Health Care—A Systematic Review , 2012 .

[15]  Gerald Gartlehner,et al.  [GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence]. , 2013, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

[16]  M. Drummond,et al.  Economics methods in Cochrane systematic reviews of health promotion and public health related interventions , 2006, BMC medical research methodology.

[17]  S Bryan,et al.  The use of economic evaluations in NHS decision-making: a review and empirical investigation. , 2008, Health technology assessment.

[18]  Luke Vale,et al.  Evidence-Based Decisions and Economics: Health Care, Social Welfare, Education and Criminal Justice , 2010 .

[19]  M. Drummond,et al.  Incorporating economics evidence , 2008 .

[20]  S. Bryan,et al.  Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. , 2008, Health technology assessment.

[21]  A. Dhar,et al.  National Institute for Health and Clinical Excellence , 2005 .

[22]  and Quality Assessing the Impact of Economic Evidence on Policymakers In Health Care - A Systematic Review , 2013 .

[23]  A. L. Cochrane,et al.  Effectiveness and efficiency: random reflections on health services , 1972 .

[24]  F. Pang,et al.  Generalisability in economic evaluation studies in healthcare: a review and case studies. , 2004, Health technology assessment.